Selinexor with Choline Salicylate
Phase Ib Trial of Low-Dose Selinexor (KPT-330) in Combination With Choline Salicylate (CS) for the Treatment of Patients With Non-Hodgkin Lymphoma (NHL), Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasms, or Multiple Myeloma
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 39 patients (estimated)
- Sponsors
- Mayo Clinic
- Collaborators
- National Cancer Institute (NCI)
- Tags
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Selective Inhibiton of Nuclear Export (SINE)
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1903
- NCT Identifier
- NCT04640779
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.